FIELD: organic chemistry, medicine, gynecology.
SUBSTANCE: invention relates to using compound of the formula (I): or its isomers, pharmaceutically acceptable salt, or its metabolite of the following group: TORE VI [4-hydroxy-(deaminohydroxy)-toremifene], TORE VII [(4,4'-dihydroxy-(deaminohydroxy)-toremifene, TORE XVIII [(deaminocarboxy)-toremifene, TORE VIII [4-hydroxy-(deaminocarboxy)-toremifene, TORE XIII (toremifene monophenol) for preparing a pharmaceutical composition used in inhibition of urogenital atrophy in women, or in treatment or prophylaxis of symptoms associated with this pathology. Invention provides the improved inhibition of this atrophy and relief of its symptoms based on the enhanced pattern of estrogenic and anti-estrogenic effect of used compounds as compared with the known SERM.
EFFECT: improved, enhanced and valuable medicinal properties of method.
5 cl, 4 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR IMPROVING BIOLOGICAL AVAILABILITY OF OSPEMIFENE | 2005 |
|
RU2385716C2 |
SOLID PREPARATIVE FORMS OF OSPEMIFENE | 2005 |
|
RU2423113C2 |
SOLID FORMULATIONS OF OSPEMIFENE | 2005 |
|
RU2675624C2 |
METHOD FOR TREATING CLIMACTERIC DISORDERS IN WOMEN EITHER DURING OR AFTER MENOPAUSE | 2001 |
|
RU2268035C2 |
COMPOSITION FOR USE IN PREVENTION AND/OR TREATMENT OF PATHOLOGIES OF MUCOUS MEMBRANE OF GENITOURINARY SYSTEM | 2019 |
|
RU2810844C2 |
METHOD OF SUPPRESSION OF SKIN AND VAGINA ATROPHY | 1994 |
|
RU2143897C1 |
METHOD OF TREATING CHRONIC ABACTERIAL PROSTATITIS WITH SELECTIVE MODULATORS OF ESTROGEN RECEPTORS OR AROMATASE INHIBITORS | 2007 |
|
RU2480207C2 |
TREATING VAGINAL ATROPHY IN FEMALES AT RISK OF TUMORAL PATHOLOGY | 2009 |
|
RU2504381C2 |
METHOD FOR ATROPHIC VAGINITIS TREATMENT | 2017 |
|
RU2646453C1 |
METHOD OF TREATING CLIMACTERIC AND UROGENITAL DISORDERS IN WOMEN IN POSTMENOPAUSE AT BACKGROUND OF HYPOTHYROIDISM | 2012 |
|
RU2535112C2 |
Authors
Dates
2008-02-27—Published
2003-05-14—Filed